NanoScreen Awarded ISO 9001:2008 Certification
July 15, 2015
Charleston, SC -- NanoScreen, an industry leader in automated liquid handling, announced today that it’s quality management system processes have been certified as compliant under the ISO 9001:2008 standard. This certification applies to NanoScreen’s management system governing the product design, manufacturing and sales of instruments and consumables. “As one of the leading liquid handling providers, [...]
Biotage® ACT Plate Adapter Prevents Evaporative Cross-Talk
July 15, 2015
Uppsala, Sweden -- Biotage® (STO: BIOT), a leading global supplier of solutions and technology for analytical and medicinal chemistry, announces the launch of Biotage® ACT (Anti Cross Talk) Plate Adapter, an innovative solution for prevention of well to well cross contamination during extract evaporation. Biotage® ACT Plate Adapter is an essential accessory for evaporation devices. [...]
July 15, 2015
BOTHELL, WA — BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and related cloud hosted biologistics cold chain management app for smart shippers today announced that manufacturing process validation has commenced to support the launch of a new product, [...]
July 15, 2015
SEATTLE -- NanoString Technologies, Inc. (Nasdaq:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the expansion of the nCounter Analysis System product portfolio with the launch of the nCounter SPRINT Profiler. Sales of the new system have already begun, with the first two SPRINT systems being purchased in [...]
Medtown Ventures, LLC Announces Exclusive License Agreement with Georgia Tech Research Corporation
July 15, 2015
Marietta, GA - Medtown Ventures, LLC (“Medtown”), a venture development firm that specializes in the capitalization and commercialization of promising life science companies today announced that it has entered into an exclusive license agreement with Georgia Tech Research Corporation for a new adhesive-signature based stem cell selection and isolation technology. To focus on the commercialization [...]
Qlucore announces 3 year license from Europe’s largest biopharmaceutical company
July 15, 2015
LUND, SWEDEN -- Qlucore, a world leader in the development of bioinformatics software, has announced a three year license contract with Actelion, one of Europe?s leading biopharmaceutical companies. Actelion is a leader in the science and medicine of pulmonary arterial hypertension (PAH), and its understanding of the complex pathways and molecular mechanisms of this disease [...]
July 15, 2015
WILMINGTON, Mass. -- Implant Sciences Corporation(OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has shipped an additional approximately $1.2 million of its explosives trace detectors to customers around the world. The sales were comprised of both its QS-B220 desktop explosives [...]
Geneuity Adopts Thermo Fisher’s Oncomine Assay to Expand Pharmaceutical Services
July 15, 2015
CARLSBAD, Calif. -- Geneuity, a leader in the integration of molecular diagnostics and pathology testing for pharma, contract research organizations, and medical device companies, today announced that it is expanding early access to Thermo Fisher Scientific’s targeted, next-generation sequencing (NGS) technology and Oncomine Focus Assay for services it plans to offer to its broad pharmaceutical [...]
IDEX Corporation Names Eric Ashleman as Chief Operating Officer
July 15, 2015
LAKE FOREST, Ill. -- IDEX CORPORATION (NYSE: IEX) today announced the promotion of Eric Ashleman to the position of Senior Vice President and Chief Operating Officer, effective immediately. Mr. Ashleman will continue to report to Andrew Silvernail, IDEX Chairman and Chief Executive Officer. Mr. Ashleman will be responsible for the operations of all IDEX business [...]
Rubicon Genomics Raises $2 Million To Support Strong Growth Momentum
July 15, 2015
Ann Arbor, MI –– Rubicon Genomics, Inc., a provider of innovative pre-analytical reagent kits to improve the performance of genomic analytical platforms and enable the use of liquid biopsies, today announced that it has completed a $2 million growth capital financing. The financing was led by BroadOak Capital Partners, a life sciences focused merchant bank, [...]

